When searching for tumor markers, much attention is paid to the tumor subtype, which is determined by the presence (or absence) of the estrogen receptor (ER), progesterone receptor (PR), and the protein associated with the human epidermal growth factor receptor (HER2). Here, ERBB2 is linked to neoplasm.